Stakeholder Political Alliance for Radioligand Cancer Therapies

Tweet this page
<
2025
>
Registration as it was on 03 Jan 2025
How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2024 - Dec 2024

Lobbyists (Full time equivalent)

1.25 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Stakeholder Political Alliance for Radioligand Cancer Therapies   (SPARC-Europe)

    EU Transparency Register

    256554395263-45 First registered on 03 Jan 2025

    Goals / Remit

    SPARC-Europe is a European policy initiative, launched in October 2020, aiming to build a comprehensive policy framework for radioligand therapies. The mission of the group is to provide expert knowledge and the necessary guidance for policymakers to support them in the creation of a clear pathway to institutionalise radioligand therapies and increase its accessibility for patients.

    The overarching objective of the group is to work together with its Patron policymakers towards accommodating European innovation and changing the outcomes for cancer patients.

    Main EU files targeted

    Europe's Beating Cancer Plan
    Strategic Agenda for Medical, Industrial and Research Applications (SAMIRA)
    EU4Health Programme
    Pharmaceutical legislation

    Address

    Head Office
    C/O RPP Group 10 Rue Guimard,1040 Brussels, BELGIUM
    BRUSSELS 1040
    BELGIUM
    EU Office
    C/O RPP Group 10 Rue Guimard,1040 Brussels, BELGIUM
    BRUSSELS 1040
    BELGIUM

    Website

    http://sparc-europe.com/

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    50%2
    25%1

    Lobbyists (Full time equivalent)

    1.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    SPARC-Europe activities are supported by policy secretariat, RPP Group, which is responsible for the day-to-day management of the Alliance, including implementation of work programme, regular communication between its members, workstreams, the Steering Committee and Political Patrons.

    The Alliance is governed by an independent Steering Committee, composed of a wide range of experts in the field of oncology, internal medicine, nuclear medicine, radioligand therapies, patient advocacy. The Steering Committee members act voluntarily and as experts in their respective fields.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    https://sparc-europe.com/governance

    Member organisations

    https://sparc-europe.com/about/members

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2024 - Dec 2024

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    75,000€

    Major funding types in closed year

    Grants

    Major contributions in closed year

    TypeNameAmount
    Contribution Advanced Accelerator Applications 45,000€
    Contribution ITM Isotope Technologies 30,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    Cancer,Competitive European Industry: long-term and sustainable investment

    Communication activities

    High-Level Position Paper on improving Access to Radioligand Cancer Therapies in the Context of Europe's Beating Cancer Plan.
    Investment Pathway Guide for the delivery of radioligand cancer therapies, looking into the potential offered by EU funding instruments in tackling inequalities in hospital infrastructures.

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

Download this datacard